Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


read more


MC Services AG is looking forward to BIO-Europe 2016 in Cologne


Organized by the EBD Group, the 22nd BIO-Europe, the international partnering conference, this year will take place in Cologne, Germany from November 7 to 9, 2016. Serving the global life science industry, BIO-Europe offers various opportunities for high quality networking by attracting a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. As media partner, MC Services invites local and international journalist to the event and keeps them informed on the presenting company executives and attending investors. Additional Information on MC Services’ engagement and activities during the conference will be announced soon.


Please follow us on Twitter (@MCServicesAG)

Xenikos to participate in BIO-Europe(R) 2016 - 22nd Annual International Partnering Conference


Ergomed notes co-development partner Dilaforette's intention to conduct an Initial Public Offering and change of name to Modus Therapeutics


US FDA considers Newron’s re-submitted NDA for Xadago® to be a complete, class 2 response to Complete Response Letter PDUFA date March 21, 2017


RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis


MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody


Transgene Reports Third Quarter 2016 Financial Results


Cancellation of trading listing on Xetra


AiCuris' licensee MSD says Letermovir, an investigational prophylactic therapy against HCMV in bone marrow transplant patients, met Primary Endpoint in Pivotal Phase III Study 


Positive Remimazolam phase III colonoscopy results presented at the 2016 american college of gastroenterology annual scientific meeting


First Patient Randomized in Multiple Dose Cohort of Phase 1/1b Trial with Transgene’s TG1050 in Chronic Hepatitis B Patients


MorphoSys Presents Updated Clinical Results for MOR202 at Medical Conference